[Uncommon bladder tumours].

Area of Science:

• Uro-oncology
• Pathology
• Cancer Research

Context:

• Bladder tumors are common, with over 10,000 new cases annually in France.
• Fewer than 500 cases involve non-transitional cell carcinoma subtypes.
• Accurate pathological identification via transurethral resection biopsy is essential.

Purpose:

• To highlight the importance of precise pathological pattern evaluation in bladder tumors.
• To discuss various non-transitional cell carcinoma subtypes and their characteristics.
• To outline treatment strategies and prognostic outcomes for different bladder tumor types.

Summary:

• Non-transitional cell carcinomas, including sarcomatoid, squamous, and adenocarcinomatous variants, often present as pathological variants of transitional cell carcinoma.
• These rare bladder cancers, sometimes linked to drug metabolites or radiotherapy, frequently have a poor prognosis, necessitating aggressive treatment like chemotherapy and radical cystectomy.
• Other locally invasive tumors such as urachal adenocarcinomas and sarcomas require aggressive surgical excision for potentially better outcomes. Primary non-Hodgkin lymphomas of the bladder are rare, but secondary involvement is more common.

Impact:

• Emphasizes the critical need for accurate pathological assessment and disease staging in bladder cancer management.
• Informs clinical decision-making for rare bladder tumor subtypes, guiding treatment selection.
• Contributes to understanding the diverse origins and behaviors of bladder neoplasms, potentially improving patient prognosis.